Nomura Asset Management CO LTD Adc Therapeutics Sa Transaction History

Nomura Asset Management CO LTD

16 transactions

Quarter	Operation	Price Per share
Q1 2023 Jan 10, 2025	BUY	$1.92 - $5.45 $0 - $0
Q1 2023 May 11, 2023	BUY	$1.92 - $5.45 $0 - $0
Q4 2022 Jan 10, 2025	BUY	$2.87 - $5.24 $0 - $0
Q4 2022 Feb 14, 2023	BUY	$2.87 - $5.24 $0 - $0
Q3 2022 Jan 10, 2025	BUY	$4.66 - $10.31 $0 - $0
Q3 2022 Nov 14, 2022	BUY	$4.66 - $10.31 $0 - $0
Q3 2022 Nov 10, 2022	BUY	$4.66 - $10.31 $0 - $0
Q3 2022 Nov 10, 2022	BUY	$4.66 - $10.31 $0 - $0
Q2 2022 Jan 10, 2025	BUY	$5.96 - $14.99 $0 - $0
Q2 2022 Aug 12, 2022	BUY	$5.96 - $14.99 $0 - $0
Q1 2022 Jan 10, 2025	BUY	$13.28 - $20.03 $0 - $0
Q1 2022 May 13, 2022	BUY	$13.28 - $20.03 $0 - $0
Q4 2021 Jan 10, 2025	BUY	$19.29 - $31.51 $0 - $0
Q4 2021 Feb 01, 2022	BUY	$19.29 - $31.51 $0 - $0
Q3 2021 Jan 10, 2025	BUY	$20.45 - $30.0 $0 - $0
Q3 2021 Nov 12, 2021	BUY	$20.45 - $30.0 $0 - $0

53.5M

28K

60.4K

Ticker ADCT
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 77,645,296
Market Cap $124M
Description
ADC Therapeutics SA, a commercial-stage biotechnology company, develops antibody drug conjugates (ADC) for patients suffering from hematological malignancies and solid tumors. Its flagship product ZYNLONTA that is in Phase II clinical trial for the treatment of relapsed or refractory diffuse large B-cell lymphoma (DLBCL) and follicular lymphoma;...

Get notified when there are updates to the investment portfolio of Nomura Asset Management CO LTD, based on Form 13F filings with the SEC.

Stay updated on Nomura Asset Management CO LTD with notifications on news.